DepoMed (DEPO)

Add to Watchlists
Create an Alert
12.87 +0.04  +0.31% NASDAQ Apr 17, 8:00PM BATS Real time Currency in USD
View Full Chart
DEPO Price Chart
View All Events

DEPO Events

Date Type Description
Feb 26 Misc DepoMed, Inc. Q4 2013 Earnings Conference Call
Feb 25 Earnings DepoMed, Inc. Q4 2013 Earnings Results. Estimate: -0.20.
Dec 17 Misc Depomed Acquires Cambia Conference Call
Nov 05 Misc Q3 2013 Depomed Earnings Conference Call
Nov 05 Earnings Depomed to Report Third Quarter Fiscal Year 2013 Financial Results on Tuesday, November 5, 2013. Estimate: 0.06.
Aug 07 Misc Q2 2013 Depomed Earnings Conference Call
Aug 07 Earnings Depomed to Report Second Quarter Fiscal Year 2013 Financial Results on Wednesday, August 7, 2013. Estimate: -0.03.
Jul 29 Misc Depomed Announces Acquisition of Lazandaâ® (Fentanyl) Nasal Spray From Archimedes Pharma Limited
May 08 Misc Q1 2013 Depomed Earnings Conference Call
May 08 Earnings Depomed to Report First Quarter Fiscal Year 2013 Financial Results on Wednesday, May 8, 2013. Estimate: -0.05.
View All Performance Charts

DEPO Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). DepoMed is up 143.8% over the last year vs S&P 500 Total Return up 23.54%, Lannett Company up 215.9%, and Furiex Pharmaceuticals up 127.7%.

Get Quote for

PDF Report for DEPO

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download DEPO Pro Report PDF
Advertisement

Portfolio Strategies Featuring DEPO

Did DepoMed make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

DEPO Profile

  • Sector: Healthcare
  • Industry: Drug Manufacturers - Specialty & Generic
  • Headquarters Country: United States
  • Headquarters State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: California
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Depomed, Inc., is a specialty pharmaceutical company focused on pain and other conditions and diseases of the central nervous system.

Recent Quotes

Symbol Price Chg Chg % Market Cap
DEPO 12.87 +0.04 +0.31% 738.35M
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.